Cheryl Teruya
Biographic Data
| ID | 264845 |
|---|---|
| NAME | Cheryl Teruya |
| GIVEN NAMES | Cheryl |
| FAMILY NAME | Teruya |
| SIGNATURE | TERUYA C |
| AFFILIATIONS | University of California, Los Angeles |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 4 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2014 |
| H-INDEX | 1 |
Patient Perspectives on Buprenorphine/Naloxone
This study examines the barriers and facilitators of retention among patients receiving buprenorphine/naloxone at eight community-based opioid treatment programs across the United States. Participants (n = 105) were recruited up to three and a half years after having participated in a randomized clinical trial comparing the effect of buprenorphine/naloxone and methadone on liver function. Semi-structured interviews were conducted with 67 patients…
Impact of California’s Proposition 36 on the Drug Treatment System
Objectives. California’s Proposition 36 offers nonviolent drug offenders community-based treatment as an alternative to incarceration or probation without treatment. We examined how treatment capacity changed to accommodate Proposition 36 clients and whether displacement of other clients was an unintended consequence. Methods. Treatment admissions were compared for the year before and 2 years after the law was enacted. Surveys of county administr…
Implementation of a Statewide Outcome Monitoring System
The authors analyze the pilot implementation of a statewide automated outcome monitoring system (OMS) in California, using the perspectives of substance abuse treatment providers responsible for its day-to-day operation. To gain a better understanding of changes experienced by staff and their perceptions of barriers and facilitators of implementation, they conducted 28 focus groups designed to inform midstream adjustments to the system prior to i…
Impact of California’s Proposition 36 on the Drug Treatment System
Objectives. California’s Proposition 36 offers nonviolent drug offenders community-based treatment as an alternative to incarceration or probation without treatment. We examined how treatment capacity changed to accommodate Proposition 36 clients and whether displacement of other clients was an unintended consequence. Methods. Treatment admissions were compared for the year before and 2 years after the law was enacted. Surveys of county administr…
Implementation of a Statewide Outcome Monitoring System
The authors analyze the pilot implementation of a statewide automated outcome monitoring system (OMS) in California, using the perspectives of substance abuse treatment providers responsible for its day-to-day operation. To gain a better understanding of changes experienced by staff and their perceptions of barriers and facilitators of implementation, they conducted 28 focus groups designed to inform midstream adjustments to the system prior to i…
Implementation of a Statewide Outcome Monitoring System
The authors analyze the pilot implementation of a statewide automated outcome monitoring system (OMS) in California, using the perspectives of substance abuse treatment providers responsible for its day-to-day operation. To gain a better understanding of changes experienced by staff and their perceptions of barriers and facilitators of implementation, they conducted 28 focus groups designed to inform midstream adjustments to the system prior to i…
Impact of California’s Proposition 36 on the Drug Treatment System
Objectives. California’s Proposition 36 offers nonviolent drug offenders community-based treatment as an alternative to incarceration or probation without treatment. We examined how treatment capacity changed to accommodate Proposition 36 clients and whether displacement of other clients was an unintended consequence. Methods. Treatment admissions were compared for the year before and 2 years after the law was enacted. Surveys of county administr…
Patient Perspectives on Buprenorphine/Naloxone
This study examines the barriers and facilitators of retention among patients receiving buprenorphine/naloxone at eight community-based opioid treatment programs across the United States. Participants (n = 105) were recruited up to three and a half years after having participated in a randomized clinical trial comparing the effect of buprenorphine/naloxone and methadone on liver function. Semi-structured interviews were conducted with 67 patients…
Medicine (3 works) · Substance Abuse Treatment and Outcomes (3 works) · Nursing (2 works) · Psychology (2 works) · Qualitative research (2 works) · Anesthesia (1 works) · Buprenorphine (1 works) · Business (1 works) · Clinical trial (1 works) · Community Health and Development (1 works)